AU2007275068B2 - Transcription infidelity, detection and uses thereof - Google Patents

Transcription infidelity, detection and uses thereof Download PDF

Info

Publication number
AU2007275068B2
AU2007275068B2 AU2007275068A AU2007275068A AU2007275068B2 AU 2007275068 B2 AU2007275068 B2 AU 2007275068B2 AU 2007275068 A AU2007275068 A AU 2007275068A AU 2007275068 A AU2007275068 A AU 2007275068A AU 2007275068 B2 AU2007275068 B2 AU 2007275068B2
Authority
AU
Australia
Prior art keywords
protein
sequence
transcription infidelity
cancer
transcription
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007275068A
Other languages
English (en)
Other versions
AU2007275068A1 (en
Inventor
Bernard Bihain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transmedi SA
Original Assignee
Transmedi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transmedi SA filed Critical Transmedi SA
Publication of AU2007275068A1 publication Critical patent/AU2007275068A1/en
Application granted granted Critical
Publication of AU2007275068B2 publication Critical patent/AU2007275068B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Glass Compositions (AREA)
  • Pit Excavations, Shoring, Fill Or Stabilisation Of Slopes (AREA)
  • Peptides Or Proteins (AREA)
AU2007275068A 2006-07-20 2007-07-20 Transcription infidelity, detection and uses thereof Ceased AU2007275068B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06291176A EP1887088A1 (en) 2006-07-20 2006-07-20 Transcription infidelity, detection and uses thereof
EP06291176.3 2006-07-20
PCT/EP2007/057541 WO2008009751A2 (en) 2006-07-20 2007-07-20 Transcription infidelity, detection and uses thereof

Publications (2)

Publication Number Publication Date
AU2007275068A1 AU2007275068A1 (en) 2008-01-24
AU2007275068B2 true AU2007275068B2 (en) 2013-06-06

Family

ID=37496681

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007275068A Ceased AU2007275068B2 (en) 2006-07-20 2007-07-20 Transcription infidelity, detection and uses thereof

Country Status (18)

Country Link
US (1) US8288091B2 (enExample)
EP (3) EP1887088A1 (enExample)
JP (1) JP5298013B2 (enExample)
KR (1) KR101502179B1 (enExample)
AT (1) ATE524565T1 (enExample)
AU (1) AU2007275068B2 (enExample)
BR (1) BRPI0714563B8 (enExample)
CA (1) CA2658305C (enExample)
CY (2) CY1112125T1 (enExample)
DK (2) DK2046986T3 (enExample)
ES (2) ES2373428T3 (enExample)
HU (1) HUE028135T2 (enExample)
IL (1) IL196600A0 (enExample)
PL (2) PL2046986T3 (enExample)
PT (2) PT2046986E (enExample)
SI (2) SI2468885T1 (enExample)
TR (1) TR201112295Y (enExample)
WO (1) WO2008009751A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2071334A1 (en) * 2007-12-14 2009-06-17 Transmedi SA Compositions and methods of detecting TIABS
EP2080812A1 (en) 2008-01-18 2009-07-22 Transmedi SA Compositions and methods of detecting post-stop peptides
EP2995688A1 (en) 2014-09-12 2016-03-16 Genclis Methods of prognosing and treating triple negative breast cancer
WO2017100789A1 (en) * 2015-12-11 2017-06-15 Expression Pathology, Inc. Srm/mrm assays
LT3430390T (lt) 2016-03-18 2022-11-25 Genclis Molekulinė alergijos kilmė
WO2018187216A1 (en) * 2017-04-03 2018-10-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Expression cassettes and methods for detecting transcription errors
EP3700856A4 (en) 2017-10-26 2021-12-15 Ultima Genomics, Inc. METHODS AND SYSTEMS FOR SEQUENCE CALL
CN113795887A (zh) 2019-03-10 2021-12-14 阿尔缇玛基因组学公司 用于序列判定的方法和系统
WO2021030271A2 (en) 2019-08-09 2021-02-18 Nutcracker Therapeutics, Inc. Methods and apparatuses for manufacturing for removing material from a therapeutic composition
KR102334576B1 (ko) * 2019-08-12 2021-12-07 한국생명공학연구원 융합 단백질 및 이를 포함하는 바이오 이미징용 조성물
EP4211268A4 (en) * 2020-09-10 2024-09-18 Ultima Genomics, Inc. SEQUENCE AND VARIANT CALLING METHODS AND SYSTEMS
WO2022108309A1 (ko) * 2020-11-18 2022-05-27 한양대학교 에리카산학협력단 인산화된 비멘틴의 과도한 생성을 차단하여 암을 예방 또는 치료하는 방법
EP4162948A1 (en) 2021-10-05 2023-04-12 Genclis Transcription infidelity derived chimeric immunogens and uses thereof
WO2023104904A2 (en) 2021-12-08 2023-06-15 Genclis The sars-cov-2 and variants use two independent cell receptors to replicate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4979330A (en) 1989-10-10 1990-12-25 Rorant Julius W Suction insect trap device
US6120992A (en) 1993-11-04 2000-09-19 Valigene Corporation Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification in a diseased human
WO2001040804A2 (en) * 1999-12-03 2001-06-07 Koninklijke Nederlandse Akademie Van Wetenschappen Clearance of aberrant protein in correlation with disease
US20020132259A1 (en) 2001-02-21 2002-09-19 Wagner Robert E. Mutation detection using MutS and RecA
WO2006053061A2 (en) * 2004-11-10 2006-05-18 Kansas State University Research Foundation Porcine reproductive and respiratory syndrome virus receptor components and uses thereof

Also Published As

Publication number Publication date
BRPI0714563A2 (pt) 2015-04-14
JP2009544284A (ja) 2009-12-17
HK1128937A1 (en) 2009-11-13
DK2046986T3 (da) 2012-01-02
PL2468885T3 (pl) 2016-04-29
KR101502179B1 (ko) 2015-03-12
CY1112125T1 (el) 2015-11-04
AU2007275068A1 (en) 2008-01-24
US8288091B2 (en) 2012-10-16
CA2658305C (en) 2017-07-18
TR201112295Y (tr) 2018-08-27
BRPI0714563B1 (pt) 2019-07-02
SI2468885T1 (sl) 2016-02-29
SI2046986T1 (sl) 2012-05-31
EP2468885A2 (en) 2012-06-27
WO2008009751A3 (en) 2008-07-31
DK2468885T3 (da) 2016-02-29
CY1116939T1 (el) 2017-04-05
US20090317386A1 (en) 2009-12-24
BRPI0714563B8 (pt) 2021-05-25
JP5298013B2 (ja) 2013-09-25
WO2008009751A2 (en) 2008-01-24
EP2468885B1 (en) 2015-08-19
ATE524565T1 (de) 2011-09-15
CA2658305A1 (en) 2008-01-24
HUE028135T2 (en) 2016-12-28
EP2046986A2 (en) 2009-04-15
IL196600A0 (en) 2009-11-18
ES2373428T3 (es) 2012-02-03
KR20090052861A (ko) 2009-05-26
EP2046986B1 (en) 2011-09-14
EP1887088A1 (en) 2008-02-13
ES2553435T3 (es) 2015-12-09
PL2046986T3 (pl) 2012-02-29
EP2468885A3 (en) 2012-08-29
PT2046986E (pt) 2011-12-29
PT2468885E (pt) 2015-11-26

Similar Documents

Publication Publication Date Title
AU2007275068B2 (en) Transcription infidelity, detection and uses thereof
EP2080812A1 (en) Compositions and methods of detecting post-stop peptides
Du et al. Chromatin interactions and candidate genes at ten prostate cancer risk loci
JP2009519710A (ja) 遺伝子発現調節エレメントのハイスループットでの特徴付けのための機能性アレイ
KR20100016568A (ko) 녹내장 발증 리스크의 판정 방법
US20120073585A1 (en) Methods of predicting complication and surgery in crohn's disease
AU2018210552A1 (en) Methods for identifying and using small RNA predictors
Alfano et al. Characterization of full-length CNBP expanded alleles in myotonic dystrophy type 2 patients by Cas9-mediated enrichment and nanopore sequencing
WO2022034300A1 (en) Multiomic analysis of nanoparticle-coronas
JP2008545390A (ja) 遺伝的多型を用いた肺癌を発達させるリスクの評価方法
CN113564162A (zh) 同源重组修复基因捕获探针组、试剂盒及其应用
WO2004053106A2 (en) Profiled regulatory sites useful for gene control
Drazdauskienė et al. Fusion sequencing via terminator‐assisted synthesis (FTAS‐seq) identifies TMPRSS2 fusion partners in prostate cancer
HK1128937B (en) Transcription infidelity, detection and uses thereof
EP4431617A1 (en) Long-read sequencing of human immunoglobulin gene introns to define a biomarker for in vivo dna break repair
Bouzarelou et al. Reclassification of Splicing Gene Variants in Hereditary Cancer: Cases Report and Literature Review
Kazeminezhad et al. In Silico Analysis of the Novel Variant Q375R in the Phenylalanine Hydroxylase Gene
WO2025188870A1 (en) Methods of diagnosing and treating inflammatory bowel disorder
Grallert et al. Omics: Potential Role in Early Phase Drug Development
JP2006314315A (ja) 肺の機能と異常を調べるための方法と組成物

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired